Angiogenic growth factors: A review for tissue engineering

Tissue Engineering

Volumn 4, Issue 2, 1998, Pages 117-130

  Ahrendt, Gretchen ^a   Chickering, Donald E ^b   Ranieri, John P ^a,c  

^a Biomaterial and Cell Technologies   (United States)

^b Acusphere Inc   (United States)

^c Sulzer Carbomedics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR; OSTEONECTIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; HEART MUSCLE ISCHEMIA; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; VASCULARIZATION;

EID: 0031804279     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1998.4.117     Document Type: Article

References (52)

1. Sage, E.H. Angiogenesis inhibition in the context of endothelial cell biology. Adv. Oncol. 12, 17, 1996.
2. Schaper, W. Collateral vessel growth in the human heart: Role of fibroblast growth factor-2. Circulation 94, 600, 1996.
3. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757, 1996.
4. Auerbach, R. Cell differentiation during embryonic angiogenesis and vasculogenesis. Presented at International Business Communications conference: "Therapeutic Implications and Mechanisms of Angiogenesis; Novel Therapeutic Development" in Boston, Feb 10-11, 1997.
5. Folkman, J. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285, 1182, 1971.
6. Rudkin, G.H., and Miller, T.A. Growth factors in surgery. Plast. Reconstr. Surg. 97, 469, 1996.
7. Banai, S., Jaklitsch, M.T., Shou, M., Lazarous, D.F., Scheinowitz, M., Biro, S., Epstein, S.E., and Unger, E.F. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183, 1994.
8. Adamis, A.P. Regulation of vascular endothelial growth factor in the eye. Presented at International Business Communications conference: "Therapeutic Implications and Mechanisms of Angiogenesis; Novel Therapeutic Development" in Boston, Feb 10-11, 1997.
9. Ware, J.A., and Simons, M. Angiogenesis in ischemic heart disease. Nat. Med. 3, 158, 1997.
10. 3 integrin, osteopontin and thrombin. Am. J. Pathol. 149, 293, 1996.
11. Eriksson, U., Olofsson, B., Pajusola, K., von Euler, G., Kaipainen, A., Joukov, V., and Alitalo, K. Vascular en- dothelial growth factor B, a novel growth factor for endothelial cells. Presented at International Business Communications conference: "Therapeutic Implications and Mechanisms of Angiogenesis; Novel Therapeutic Development" in Boston, Feb 10-11, 1997.
12. Alitalo, K., Joukov, V., Jeltsch, M., Ristimaki, A., Kukk, E., Kaipainen, A., Korpelainen, E., Kumar, V., Olofsson, B., Pettersson, R., Eriksson, U., Gunji, Y., Paavonen, K., and Enholm, B. Vascular endothelial growth factors B and C and receptors involved in angiogenesis. Presented at International Business Communications conference: "Therapeutic Implications and Mechanisms of Angiogenesis; Novel Therapeutic Development" in Boston, Feb 10-11, 1997.
13. Klagsbrun, M. Cardiovascular cell growth factors and the arterial wall. In: Haber, E., ed. Molecular Cardiovascular Medicine, New York: Scientific American, Inc., 1995, pp. 63-78.
14. Partanen, J., Vainikka, S., Korhonen, J., Armstrong, E., and Alitalo, K. Diverse receptors for fibroblast growth factors. Prog. Growth Factor Res. 4, 69, 1992.
15. Flaumenhaft, R., Abe, M., Mignatti, P., and Rifkin, D.B. Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: Regulation of plasminogen activator activity. J. Cell Biol. 118, 901, 1992.
16. Hirschi, K.K., and D'Amore, P.A. Pericytes in the microvasculature. Cardiovasc. Res. 32, 687, 1996.
17. Isner, J.M. The role of angiogenic cytokines in cardiovascular disease. Clin. Immunol. Immunopathol. 80, S82, 1996.
18. Engelmann, G.L., Dionne, C.A., and Jaye, M.C. Acidic fibroblast growth factor and heart development. Circ. Res. 72, 7, 1992.
19. Flaumenhaft, R., and Rifkin, D.B. Cell density dependent effects of TGF-β demonstrated by a plasminogen activator-based assay for TGF-β. J. Cell. Physiol. 152, 48, 1992.
20. Goad, D.L., Rubin, J., Wang, H., Tashjian, A.H., and Patteson, C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology 137, 2262, 1996.
21. Marx, M., Perlmutter, R.A., and Madri, J.A. Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest. 93, 131, 1994.
22. Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, W.S., Wakefield, L.A., Heine, U.I., Liotta, L.A., Falanga, V., Kehl, J.H., and Fauci, A.S. Transforming growth factor β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 83, 4167, 1986.
23. Cockerill, G.W., Gamble, J.R., and Vadas, M.A. Angiogenesis: Models and modulators. Int. Rev. Cytol. 159, 113, 1995.
24. 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 111, 731, 1990.
25. Sankar, S., Mahooti-Brooks, L., Bensen, L., McCarthy, T.L., Centrella, M., and Madri, J.A. Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest. 97, 1436, 1996.
26. Iwasaki, S., Tsuruoka, N., Hattori, A., Sato, M., Tsujimoto, M., and Kohno, M. Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. J. Biol. Chem. 270, 5476, 1995.
27. Schor, A.M., Canfield, A.E., Sutton, A.B., Arciniegas, E., and Allen, T.D. Pericyte differentiation. Clin. Orthop. 313, 81, 1995.
28. Sage, E.H. Terms of attachment: SPARC and Tumorigenesis. Nat. Med. 3, 144, 1997.
29. Frizell, E., Liu, S., Abraham, A., Ozaki, I., Eghbali, M., Sage, E.H., and Zern, M.A. Expression of SPARC in normal and fibrotic livers. Hepatology 21, 847, 1995.
30. Iruela-Arispe, M.L., Lane, T.F., Redmond, D., Reilly, M., Bolender, R.P., Kavanagh, T.J., and Sage, E.H. Expression of SPRAC during development of the chicken chorioallantoic membrane: Evidence for regulated proteolysis in vivo. Mol. Biol. Cell. 6, 327, 1995.
31. Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L., Jain, V., Ryan, T.E., Bruno, J., Radziejewshi, C., Maisonpierre, P.C., and Yancopoulos, G.D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161, 1996.
32. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N., Daly, T.J., Davis, S., Sato, T.N., and Yancopoulos, G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55, 1997.
33. Selwyn, A.P., and Braunwald, E. Ischemic heart disease. In: Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S., and Kasper, D.L., eds. Principles of Internal Medicine. New York: McGraw-Hill, Inc., 1994, pp. 1077-1085.
34. Lazarous, D.F., Shou, M., Scheinowitz, M., Hodge, E., Thirumurti, V., Kitsiou, A.N., Stiber, J.A., Lobo, A.D., Hunsberger, S., Guetta, E., Epstein, S.E., and Unger, E.F. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94, 1074, 1996.
35. Uchida, Y., Yanagisawa-Miwa, A., Nakamura, F., Yamada, K., Tomaru, T., Kimura, K., and Morita, T. Angiogenic therapy of acute myocardial infarction by intrapericardial injection of basic fibroblast growth factor and heparin sulfate: An experimental study. Am. Heart J. 130, 1182, 1995.
36. Harada, K., Grossman, W., Friedman, M., Edelman, E.R., Prasad, P.V., Keighley, C.S., Manning, W.J., Sellke, F.W., and Simons, M. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. 94, 623, 1994.
37. Sellke, F.W., Wang, S.Y., Friedman, M., Harada, K., Edelman, E.R., Grossman, W., and Simons, M. Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am. J. Physiol. 267, H1303, 1994.
38. Mühlhauser, J., Pili, R., Merrill, M.J., Maeda, H., Passaniti, A., Crystal, R.G., and Capogrossi, M.C. In vivo angiogenesis induced by recombinant adenovirus vector coding either for secreted or nonsecreted forms of acidif fibroblast growth factor. Hum. Gene Ther. 6, 1457, 1995.
39. Giordano, F.J., Ping, P., McKirnan, M.D., Nozaki, S., DeMaria, A.N., Dillman, W.H., Mathieu-Costello, O., and Hammond, H.K. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat. Med. 2, 534, 1996.
40. Majesky, M.W. A little VEGF goes a long way: Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA. Circulation 94, 3062, 1996.
41. Takeshita, S., Zheng, L.P., Brogi, E., Kearney, M., Pu, L., Bunting, S., Ferrara, N., Symes, J.F., and Isner, J.M. Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93, 662, 1994.
42. Yang, H.T., Deschenes, M.R., Ogilvie, R.W., and Terjung, R.L. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 79, 62, 1996.
43. Tsurumi, Y., Takeshita, S., Chen, D., Kearney, M., Rossow, S.T., Passeri, J., Horowitz, J.R., Symes, J.F., and Isner, J.M. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94, 3281, 1996.
44. 165 in patient with ischaemic limb. Lancet 348, 370, 1996.
45. Horrigan, M.C.G., Maclsaac, A.I., Nicolini, F.A., Vince, D.G., Lee, P., Ellis, S.G., and Topol, E.J. Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model. Circulation 94, 1927, 1996.
46. Asahara, T., Bauters, C., Pastore, C., Kearney, M., Rossow, S., Bunting, S., Ferrara, N., Symes, J.F., and Isner, J.M. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rate carotid artery. Circulation 91, 2793, 1995.
47. Martins-Green, M., Boudreau, N., and Bissell, M.J. Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res. 54, 4334, 1994.
48. O'Reilly, M.S. Angiostatin and endostatin: Two novel endogenous inhibitors of angiogenesis and tumor growth. In: Therapeutic Implications and Mechanisms of Angiogenesis: Novel Therapeutic Development. Boston, 1997.
49. Nabel, E.G., Yang, Z., Plautz, G., Forough, R., Zhan, x., Haudenschild, C.C., Maciag, T., and Nabel, G.J. Recombinant fibroblast growth factor-1 promotes intimai hyperplasia and angiogenesis in arteries in vivo. Nature 362, 844, 1993.
50. Lazarous, D.F., Scheinowitz, M., Shou, M., Hodge, E., Rajanayagam, M.A.S., Hunsberger, S., Robison, W.G., Stiber, J.A., Correa, R., Epstein, S.E., and Unger, E.F. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91, 145, 1995.
51. Madri, J.A., and Pratt, B.M. Angiogenesis. In: Clark, R.A.F., and Henson, P.M., eds. Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1988, pp. 337-358.
52. Guyton, A.C. Transport of oxygen and carbon dioxide in the blood and body fluids. In: Textbook of Medical Physiology. Philadelphia: W.B. Saunders Company, 1986, pp. 493-503.